Compare PUK & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PUK | GEHC |
|---|---|---|
| Founded | 1848 | 1892 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Computer Software: Prepackaged Software |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.4B | 35.8B |
| IPO Year | N/A | 2022 |
| Metric | PUK | GEHC |
|---|---|---|
| Price | $29.59 | $72.15 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $90.83 |
| AVG Volume (30 Days) | 744.6K | ★ 2.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.58% | 0.19% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | $8.03 | $4.50 |
| P/E Ratio | $23.76 | ★ $15.93 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $17.79 | $57.65 |
| 52 Week High | $34.03 | $89.77 |
| Indicator | PUK | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 33.55 |
| Support Level | $28.70 | $69.64 |
| Resistance Level | $30.02 | $74.29 |
| Average True Range (ATR) | 0.61 | 2.05 |
| MACD | -0.01 | -0.80 |
| Stochastic Oscillator | 40.03 | 19.01 |
Originally established as Prudential Mutual Assurance, Investment, and Loan Association in 1848, Prudential plc has moved on a lot since then. Set up to sell life insurance and loans to the middle and then the industrializing and urbanizing working classes, the company subsequently diversified into Europe and then North America with the purchase of Jackson National Life in around 1985. During its time as owner of Jackson, Prudential focused on building out a simple chassis-style product portfolio where customers could choose a variety of add-ons. The company also became renowned for its focus on building requisite internal capabilities to support its strong product offerings, including compelling technology and a large and well-trained wholesale sales.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).